198 related articles for article (PubMed ID: 34668421)
1. Separating the contributions of SLC26A9 and CFTR to anion secretion in primary human bronchial epithelia.
Larsen MB; Choi JJ; Wang X; Myerburg MM; Frizzell RA; Bertrand CA
Am J Physiol Lung Cell Mol Physiol; 2021 Dec; 321(6):L1147-L1160. PubMed ID: 34668421
[TBL] [Abstract][Full Text] [Related]
2. The anion transporter SLC26A9 localizes to tight junctions and is degraded by the proteasome when co-expressed with F508del-CFTR.
Sato Y; Thomas DY; Hanrahan JW
J Biol Chem; 2019 Nov; 294(48):18269-18284. PubMed ID: 31645438
[TBL] [Abstract][Full Text] [Related]
3. Synergy in Cystic Fibrosis Therapies: Targeting SLC26A9.
Pinto MC; Quaresma MC; Silva IAL; Railean V; Ramalho SS; Amaral MD
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884866
[TBL] [Abstract][Full Text] [Related]
4. SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia.
Bertrand CA; Zhang R; Pilewski JM; Frizzell RA
J Gen Physiol; 2009 Apr; 133(4):421-38. PubMed ID: 19289574
[TBL] [Abstract][Full Text] [Related]
5. The CFTR trafficking mutation F508del inhibits the constitutive activity of SLC26A9.
Bertrand CA; Mitra S; Mishra SK; Wang X; Zhao Y; Pilewski JM; Madden DR; Frizzell RA
Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L912-L925. PubMed ID: 28360110
[TBL] [Abstract][Full Text] [Related]
6. The SLC26A9 inhibitor S9-A13 provides no evidence for a role of SLC26A9 in airway chloride secretion but suggests a contribution to regulation of ASL pH and gastric proton secretion.
Jo S; Centeio R; Park J; Ousingsawat J; Jeon DK; Talbi K; Schreiber R; Ryu K; Kahlenberg K; Somoza V; Delpiano L; Gray MA; Amaral MD; Railean V; Beekman JM; Rodenburg LW; Namkung W; Kunzelmann K
FASEB J; 2022 Nov; 36(11):e22534. PubMed ID: 36183361
[TBL] [Abstract][Full Text] [Related]
7. Pendrin Mediates Bicarbonate Secretion and Enhances Cystic Fibrosis Transmembrane Conductance Regulator Function in Airway Surface Epithelia.
Kim D; Huang J; Billet A; Abu-Arish A; Goepp J; Matthes E; Tewfik MA; Frenkiel S; Hanrahan JW
Am J Respir Cell Mol Biol; 2019 Jun; 60(6):705-716. PubMed ID: 30742493
[TBL] [Abstract][Full Text] [Related]
8. Slc26a9 is inhibited by the R-region of the cystic fibrosis transmembrane conductance regulator via the STAS domain.
Chang MH; Plata C; Sindic A; Ranatunga WK; Chen AP; Zandi-Nejad K; Chan KW; Thompson J; Mount DB; Romero MF
J Biol Chem; 2009 Oct; 284(41):28306-28318. PubMed ID: 19643730
[TBL] [Abstract][Full Text] [Related]
9. Expression of SLC26A9 in Airways and Its Potential Role in Asthma.
Ousingsawat J; Centeio R; Schreiber R; Kunzelmann K
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328418
[TBL] [Abstract][Full Text] [Related]
10. Differential contribution of SLC26A9 to Cl(-) conductance in polarized and non-polarized epithelial cells.
Ousingsawat J; Schreiber R; Kunzelmann K
J Cell Physiol; 2012 Jun; 227(6):2323-9. PubMed ID: 21809345
[TBL] [Abstract][Full Text] [Related]
11. SLC26A9 as a Potential Modifier and Therapeutic Target in Cystic Fibrosis Lung Disease.
Gorrieri G; Zara F; Scudieri P
Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204703
[TBL] [Abstract][Full Text] [Related]
12. Loss of Slc26a9 anion transporter alters intestinal electrolyte and HCO3(-) transport and reduces survival in CFTR-deficient mice.
Liu X; Li T; Riederer B; Lenzen H; Ludolph L; Yeruva S; Tuo B; Soleimani M; Seidler U
Pflugers Arch; 2015 Jun; 467(6):1261-75. PubMed ID: 24965066
[TBL] [Abstract][Full Text] [Related]
13. Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics.
Strug LJ; Gonska T; He G; Keenan K; Ip W; Boëlle PY; Lin F; Panjwani N; Gong J; Li W; Soave D; Xiao B; Tullis E; Rabin H; Parkins MD; Price A; Zuberbuhler PC; Corvol H; Ratjen F; Sun L; Bear CE; Rommens JM
Hum Mol Genet; 2016 Oct; 25(20):4590-4600. PubMed ID: 28171547
[TBL] [Abstract][Full Text] [Related]
14. Extent of rescue of F508del-CFTR function by VX-809 and VX-770 in human nasal epithelial cells correlates with SNP rs7512462 in SLC26A9 gene in F508del/F508del Cystic Fibrosis patients.
Kmit A; Marson FAL; Pereira SV; Vinagre AM; Leite GS; Servidoni MF; Ribeiro JD; Ribeiro AF; Bertuzzo CS; Amaral MD
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1323-1331. PubMed ID: 30716472
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of Cystic Fibrosis Transmembrane Conductance Regulator Function in Human Bronchial Epithelial Cells via SLC6A14-Dependent Amino Acid Uptake. Implications for Treatment of Cystic Fibrosis.
Ahmadi S; Wu YS; Li M; Ip W; Lloyd-Kuzik A; Di Paola M; Du K; Xia S; Lew A; Bozoky Z; Forman-Kay J; Bear CE; Gonska T
Am J Respir Cell Mol Biol; 2019 Dec; 61(6):755-764. PubMed ID: 31189070
[TBL] [Abstract][Full Text] [Related]
16. Alternative chloride transport pathways as pharmacological targets for the treatment of cystic fibrosis.
Quesada R; Dutzler R
J Cyst Fibros; 2020 Mar; 19 Suppl 1():S37-S41. PubMed ID: 31662238
[TBL] [Abstract][Full Text] [Related]
17. Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells.
Michaels WE; Bridges RJ; Hastings ML
Nucleic Acids Res; 2020 Jul; 48(13):7454-7467. PubMed ID: 32520327
[TBL] [Abstract][Full Text] [Related]
18. SLC26A9 stimulates CFTR expression and function in human bronchial cell lines.
Avella M; Loriol C; Boulukos K; Borgese F; Ehrenfeld J
J Cell Physiol; 2011 Jan; 226(1):212-23. PubMed ID: 20658517
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-17A induces bicarbonate secretion in normal human bronchial epithelial cells.
Kreindler JL; Bertrand CA; Lee RJ; Karasic T; Aujla S; Pilewski JM; Frizzell RA; Kolls JK
Am J Physiol Lung Cell Mol Physiol; 2009 Feb; 296(2):L257-66. PubMed ID: 19074559
[TBL] [Abstract][Full Text] [Related]
20. Functional interaction of the cystic fibrosis transmembrane conductance regulator with members of the SLC26 family of anion transporters (SLC26A8 and SLC26A9): physiological and pathophysiological relevance.
El Khouri E; Touré A
Int J Biochem Cell Biol; 2014 Jul; 52():58-67. PubMed ID: 24530837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
